-
PDF
- Split View
-
Views
-
Cite
Cite
Corrigendum to: Master protocol trial design for efficient and rational evaluation of novel therapeutic oncology devices, JNCI: Journal of the National Cancer Institute, Volume 114, Issue 2, February 2022, Page 326, https://doi.org/10.1093/jnci/djab110
Close - Share Icon Share
Corrigendum to: Master protocol trial design for efficient and rational evaluation of novel therapeutic oncology devices by Danielle S. Bitterman, Daniel N. Cagney, Lisa L. Singer, Paul L. Nguyen, Paul J. Catalano, Raymond H Mak. JNCI: J Natl Cancer Inst (2020); 112(3): djz167.
In the originally published version of this manuscript, an erroneous middle initial was included in an author’s name. The author’s full correct name is: Lisa Singer. This error has been corrected online.
© The Author(s) 2021. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]
Issue Section:
Corrigenda
